Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 52

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 52
---
 A REVERSE STOCK SPLIT RATIO RANGING FROM 1:3 TO 1:10, INCLUSIVE, AS DETERMINED BY THE BOARD IN ITS SOLE DISCRETION (Item 3 on the Proxy Card)

Our stockholders are being asked to approve an
amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging
from 1:3 to 1:10, inclusive, as may be determined at the appropriate time by the Board, in its sole discretion (the “Reverse Stock
Split”). This means that once approved by the stockholders, the Board will be able to decide whether and when to effect the Reverse
Stock Split without further action from the stockholders.

The effectiveness of this amendment or the abandonment
thereof, notwithstanding stockholder approval, will be determined by the Board, at its sole option, following the Annual Meeting any time
prior to the one-year anniversary of the meeting.

Reasons for a Reverse Stock Split

Maintaining our Listing on Nasdaq

The primary purpose of the Reverse Stock Split
is to raise the per share trading price of our common stock in order to maintain our listing on The Nasdaq Capital Market. Delisting from
Nasdaq may adversely affect our ability to raise additional financing through the public or private sale of our equity securities, may
significantly affect the ability of investors to trade in our securities and may negatively affect the value and liquidity of our common
stock. Delisting may also have other negative impacts, including potential loss of employee confidence, the loss of institutional investors,
the loss of analyst coverage or the loss of business development opportunities.

Potentially Improving the Marketability and Liquidity of our Common Stock

The Board believes that an increased stock price
may also improve the marketability and liquidity of our common stock. For example, many brokerages, institutional investors and funds
have internal policies that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending
low-priced stocks to their customers by restricting or limiting the ability to purchase such stocks on margin. Additionally, investors
may be dissuaded from purchasing stocks below certain prices because brokers’ commissions, as a percentage of the total transaction
value, can be higher for low-priced stocks.

Decreasing the Risk of Market Manipulation of our Common Stock

The Board believes that the potential increase
in stock price may reduce the risk of market manipulation of our common stock, which we believe is enhanced